The Law Offices of Vincent Wong announce that a class action lawsuit has
been commenced in the USDC for the Southern District of New York on
behalf of investors who purchased Anavex Life Sciences Corp. (NASDAQ:
AVXL) securities between May 17, 2013 and December 28, 2015.
Click here to learn about the case: http://docs.wongesq.com/AVXL-Info-Request-Form-1048.
There is no cost or obligation to you.
According to the complaint, Anavex issued misleading statements and
failed to disclose that the Company had used a paid stock promoter to
artificially inflate the Company’s share price.
On December 29, 2015, Anavex disclosed that it had received a subpoena
from the SEC on December 22, 2015. Anavex stated, in part, that “[t]he
Company believes the subpoena and investigation relate to the recent
unusual activity in the market for the Company’s shares.” Then on
December 30, 2015, Seeking Alpha published a report entitled
“Anavex: A Regulatory Target Damaged By Incriminating Evidence.” On this
news, Anavex stock fell $0.78, or 12.42%, to close at $5.50 per share.
If you suffered a loss in Anavex Life Sciences you have until February
29, 2016 to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery doesn’t require that
you serve as a lead plaintiff. To obtain additional information, contact
Vincent Wong, Esq. either via email vw@wongesq.com,
by telephone at 212.425.1140, or visit http://docs.wongesq.com/AVXL-Info-Request-Form-1048.
Vincent Wong, Esq. is an experienced attorney that has represented
investors in securities litigations involving financial fraud and
violations of shareholder rights. Attorney advertising. Prior results do
not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160205005665/en/
Copyright Business Wire 2016